Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus

NAActive, not recruitingINTERVENTIONAL
Enrollment

780

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

January 26, 2027

Study Completion Date

February 12, 2030

Conditions
Middle-high Risk Endometrial CancerSentinel Lymph Node SamplingPrognosis
Interventions
PROCEDURE

sentinel lymph node sampling (SLN)

"Total hysterectomy with/without bilateral salpingooophorectomy (THBO) plus sentinel lymph node sampling (SLN).~1. The principles of surgery procedures and post-operative adjuvant therapies will follow the latest NCCN guidelines;~2. Surgery carried out by laparotomy, laparoscope, or robotic surgery are accepted;~3. Colored dyes including indocyanine green (ICG) (preferred), methylene blue, carbon nanotube for sentinel lymph node are accepted."

PROCEDURE

pelvic lymphonodectomy (PLN)

Total hysterectomy with/without bilateral salpingooophorectomy (THBO) plus pelvic lymphonodectomy (PLN) with para-aortic sampling

Trial Locations (1)

200011

Obstetrics and Gynecology Hospital, Fudan University, Shanghai

All Listed Sponsors
collaborator

Fudan University

OTHER

collaborator

Tongji Hospital

OTHER

collaborator

West China Second University Hospital

OTHER

collaborator

Sun Yat-sen University

OTHER

collaborator

Chongqing University Cancer Hospital

OTHER

lead

Xiaojun Chen

OTHER